Your browser doesn't support javascript.
loading
Mucosal-associated invariant T (MAIT) cells are activated in the gastrointestinal tissue of patients with combination ipilimumab and nivolumab therapy-related colitis in a pathology distinct from ulcerative colitis.
Sasson, S C; Zaunders, J J; Nahar, K; Munier, C M L; Fairfax, B P; Olsson-Brown, A; Jolly, C; Read, S A; Ahlenstiel, G; Palendira, U; Scolyer, R A; Carlino, M S; Payne, M J; Cheung, V T F; Gupta, T; Klenerman, P; Long, G V; Brain, O; Menzies, A M; Kelleher, A D.
Afiliação
  • Sasson SC; Translational Gastroenterology Unit and Oxford Biomedical Research Centre, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Zaunders JJ; Centre for Applied Medical Research, St Vincent's Hospital, Sydney, Australia.
  • Nahar K; Melanoma Institute Australia and The University of Sydney, Sydney, Australia.
  • Munier CML; The Kirby Institute, University of New South Wales, Sydney, Australia.
  • Fairfax BP; Department of Oncology, Churchill Hospital, Oxford, UK.
  • Olsson-Brown A; Department of Oncology, University of Oxford, Oxford, UK.
  • Jolly C; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
  • Read SA; The Clatterbridge Cancer Centre NHS Foundation Trust and Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
  • Ahlenstiel G; The Clatterbridge Cancer Centre NHS Foundation Trust and Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
  • Palendira U; Westmead Institute of Medical Research, Sydney, Australia.
  • Scolyer RA; Western Sydney University, Sydney, Australia.
  • Carlino MS; Westmead Institute of Medical Research, Sydney, Australia.
  • Payne MJ; Department of Gastroenterology, Blacktown Hospital, Sydney, Australia.
  • Cheung VTF; Discipline of Infectious Diseases and Immunology, The University of Sydney, Sydney, Australia.
  • Gupta T; Melanoma Institute Australia and The University of Sydney, Sydney, Australia.
  • Klenerman P; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia.
  • Long GV; Melanoma Institute Australia and The University of Sydney, Sydney, Australia.
  • Brain O; Department of Medical Oncology, Westmead and Blacktown Hospitals, Sydney, Australia.
  • Menzies AM; Department of Oncology, Churchill Hospital, Oxford, UK.
  • Kelleher AD; Translational Gastroenterology Unit and Oxford Biomedical Research Centre, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Clin Exp Immunol ; 202(3): 335-352, 2020 12.
Article em En | MEDLINE | ID: mdl-32734627
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T Reguladores / Colite / Linfócitos T CD8-Positivos / Células T Invariantes Associadas à Mucosa / Ipilimumab / Nivolumabe / Mucosa Intestinal Tipo de estudo: Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T Reguladores / Colite / Linfócitos T CD8-Positivos / Células T Invariantes Associadas à Mucosa / Ipilimumab / Nivolumabe / Mucosa Intestinal Tipo de estudo: Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article